SCOPUS BIOPHARMA INC.

Insiders Scopus BioPharma Inc.

Equities

SCPS

US8091711015

Market Closed - OTC Markets Other stock markets 15:30:42 2024-06-20 EDT			5-day change	1st Jan Change
0.0001 ^USD	-50.00%		-.--%	-99.77%

2023	Scopus BioPharma Inc. Presents DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma	CI
2023	Scopus BioPharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scopus BioPharma Inc. Announces Resignation of Paul Hopper from Board of Directors	22-05-20	CI
Scopus Biopharma Inc. Announces Resignation of Ashish Sanghrajka from the Board of Directors with Effect from May 11, 2022	22-05-13	CI
Scopus BioPharma Inc. Appoints Raphael Hofstein to its Board of Directors	22-05-05	CI
Scopus Biopharma Inc. Announces Board Resignations	22-04-29	CI
Scopus BioPharma Inc. Announces Board Appointments	22-01-06	CI
Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company	21-07-12	CI
Scopus Biopharma Inc. Announces Termination of Ashish Sanghrajka from Board	21-07-09	CI
Morris C. Laster Submits Nomination to Scopus BioPharma	21-05-12	CI
Scopus Biopharma Inc. Announces Change of Board Committees	21-03-19	CI
Scopus BioPharma Inc Announces Appointment of Additional Directors	20-12-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer